cbdMD
YCBD
2 hedge funds and large institutions have $66K invested in cbdMD in 2017 Q4 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
0% more ownership
Funds ownership: 0% → 0% (+0%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
+$53.2K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$18.9K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Goldman Sachs
New York
| $49K | +$53.2K | +31 | New |
|
|
2
UBS Group
Zurich,
Switzerland
| $17K | +$18.9K | +11 | New |
|
YCBD Hedge Fund Activity: Q4 2017 in Review
2 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in cbdMD (YCBD) for Q4 2017, worth a combined $66K.
Buyers outnumbered sellers: 2 funds opened new YCBD positions and 0 closed out — a net gain of 2 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Goldman Sachs, opening a new position worth an estimated $53.2K.
- 2 institutional investors held cbdMD (YCBD) as of Q4 2017, up from 0 in Q3 2017.
- Funds reported $66K of cbdMD stock for Q4 2017.
- 2 funds opened new cbdMD positions in Q4 2017 and 0 closed out, a net change of +2 holders.
- The largest cbdMD buyer in Q4 2017 was Goldman Sachs, an estimated $53.2K added.
Based on aggregated 13F filings for Q4 2017.